Ropinirole hydrochloride mitigates oxidative stress and neuroinflammation via the PI3K-mTOR pathway in TDP-43 hiPSC-derived microglial-like cells

This study demonstrates that ropinirole hydrochloride mitigates oxidative stress and neuroinflammation in TDP-43 mutant microglial-like cells by modulating the PI3K-mTOR pathway, establishing its potential as a dual-action therapeutic targeting both neuronal and microglial dysfunction in ALS.

The Gist

The Big Picture: A City in Chaos

Imagine the human brain as a bustling, high-tech city. In this city, Motor Neurons are the power plants that keep the lights on and the trains moving (allowing us to walk and talk). Microglia are the city's sanitation workers and security guards; they clean up trash, fix broken things, and keep the peace.

In a disease called ALS (Amyotrophic Lateral Sclerosis), the power plants start failing, causing paralysis. But for a long time, scientists thought the problem was only with the power plants. This paper argues that the sanitation workers (Microglia) are also sick, and their sickness is actually making the power plants fail faster.

The Villain: The "TDP-43" Glitch

In almost all cases of ALS, a specific protein called TDP-43 gets messed up. Think of TDP-43 as the foreman's instruction manual for the sanitation workers.

• In a healthy brain: The foreman (TDP-43) stays in the office (the nucleus) and gives clear instructions.
• In ALS: The foreman gets kicked out of the office and wanders into the streets (the cytoplasm). Without the foreman in charge, the sanitation workers get confused, stressed, and start acting erratically.

The Experiment: Building a Mini-City in a Dish

The researchers wanted to see exactly how this confusion happens in human cells. Since you can't easily take brain cells out of a living person, they used a magical technology called iPSCs (induced pluripotent stem cells).

• They took skin cells, turned them into "blank slate" stem cells, and then programmed them to become Microglia (sanitation workers).
• They created two versions:
  1. Healthy Workers: With the foreman in the office.
  2. Sick Workers: With the TDP-43 foreman kicked out of the office (specifically using a mutation called M337V).

What They Found: The Sick Workers

When they looked at the "Sick Workers" (the TDP-43 mutant microglia), they found a city in chaos:

1. Oxidative Stress (Rust): The workers were covered in "rust" (oxidative stress). They were generating toxic waste that damaged everything around them.
2. The Trash Can is Broken (Autophagy): Normally, these workers have a self-cleaning mechanism to throw away their own trash. In the sick cells, this trash can was jammed. The trash piled up, making the cell sick.
3. Over-Reacting: Instead of being calm, the sick workers were hyperactive. They were eating up everything in sight (phagocytosis) and shouting inflammatory messages (cytokines) that made the whole neighborhood angry.
4. Iron Imbalance: They were struggling to manage their iron supply, which is crucial for their energy.

The Hero: Ropinirole (ROPI)

The researchers tested a drug called Ropinirole.

• Background: This drug was originally designed for Parkinson's disease to help the "train drivers" (dopamine neurons). It was already being tested for ALS, but mostly to help the power plants (motor neurons).
• The New Discovery: The researchers asked, "Can this drug also help the sanitation workers?"

The Results:

• The Rust Disappeared: Ropinirole acted like a powerful rust remover. It significantly lowered the toxic stress levels in the sick microglia.
• The Shouting Stopped: It calmed down the workers, reducing the inflammatory shouting that was hurting the power plants.
• The Trash Can: Interestingly, Ropinirole didn't fix the broken trash can (autophagy). It didn't un-jam the mechanism.
• The Verdict: Even though it didn't fix the trash can, it made the workers so much less toxic and stressed that they stopped hurting the city.

The Secret Mechanism: The "Master Switch"

How did Ropinirole do this? The researchers dug deeper and found a "Master Switch" inside the cells called the PI3K-mTOR pathway.

• Think of this pathway as the city's central traffic control system. In the sick cells, this system was stuck on "Red Light," causing gridlock and stress.
• The study suggests that Ropinirole helps flip the switch back to "Green," allowing the traffic to flow and the stress to ease, even if the trash can is still broken.

Why This Matters

This paper is a game-changer for two reasons:

1. It's Not Just About the Neurons: It proves that the sanitation workers (microglia) are a major part of the problem in ALS. If we only fix the power plants but ignore the angry sanitation workers, the city will still burn down.
2. Old Drug, New Superpower: Ropinirole is already a safe, approved drug. This study suggests it might be a "dual-action" hero: it helps the power plants and calms the sanitation workers.

The Bottom Line

Imagine ALS as a city where the sanitation workers are sick and causing a riot. This study shows that a drug called Ropinirole can calm those workers down, stop the riot, and protect the power plants, even if it doesn't fix every single broken tool in their toolbox. It opens the door to treating ALS by targeting the immune system of the brain, not just the nerve cells.

Technical Summary

1. Problem Statement

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by motor neuron loss, neuroinflammation, and the pathological aggregation of TDP-43 protein. While TDP-43 pathology is well-documented in neurons, the specific cell-autonomous dysfunction of microglia (the brain's resident immune cells) in the context of TDP-43 mutations remains poorly understood.

• Gap in Knowledge: Previous studies relied heavily on animal models or monocyte-derived macrophages, which lack the fidelity of brain-resident microglia. There is a lack of data on how TDP-43 mutations (specifically the M337V variant) intrinsically alter human microglial function, oxidative stress responses, and autophagy.
• Therapeutic Need: Existing anti-inflammatory strategies have yielded modest benefits. There is a need to identify compounds that can target both neuronal and microglial dysfunction to halt disease progression.

2. Methodology

The study utilized a rigorous isogenic human induced pluripotent stem cell (hiPSC) approach to model ALS pathology in a human-specific context.

• Cell Models:
  • Source: KOLF2.1J hiPSC line (wild-type control).
  • Genetic Engineering: CRISPR/Cas9 was used to generate isogenic lines:
    • Heterozygous TDP-43 M337V/WT.
    • Homozygous TDP-43 M337V/M337V (primary model for assays).
  • Differentiation: Cells were differentiated into microglia-like cells (iMGLs) using a modified protocol involving hematopoietic progenitor induction and maturation with specific cytokines (M-CSF, IL-34, TGF-β).
• Functional Assays:
  • Phagocytosis: Measured via uptake of pHrodo Red Zymosan particles.
  • Oxidative Stress: Quantified using CellROX DeepGreen reagent.
  • Apoptosis: Measured via Caspase-3/7 activity.
  • Autophagy/Mitophagy: Assessed via LC3B immunoblotting (with Bafilomycin A1 to block flux) and colocalization of TOM20 (mitochondria) with LC3B.
  • Cytokine Profiling: Multiplex bead-based ELISA (LEGENDplex) following LPS stimulation.
  • Iron Homeostasis: Measured Ferritin (L-Ferritin and FTH1) levels.
• Drug Treatment: Cells were treated with Ropinirole (ROPI), a dopamine D2 receptor agonist, for one week during the maturation phase.
• Omics & Computational Analysis:
  • Bulk RNA-Seq: Performed on untreated vs. ROPI-treated iMGLs (Control vs. Mutant).
  • Connectivity Map (CMap): Used to query the LINCS database to identify drugs that reverse the TDP-43 mutant transcriptional signature.
  • Pathway Analysis: Gene Ontology (GO) and KEGG enrichment to identify affected biological pathways.

3. Key Contributions

• First Isogenic Microglial Model: Established the first isogenic hiPSC-derived microglial model specifically for the TDP-43 M337V mutation, allowing for the isolation of mutation-specific effects without confounding genetic background noise.
• Dual-Target Therapeutic Validation: Demonstrated that Ropinirole, previously shown to protect motor neurons, also exerts significant therapeutic effects on microglia, broadening its potential as a dual-action ALS therapy.
• Mechanistic Insight: Identified the PI3K-Akt-mTOR pathway as a critical regulator of TDP-43 microglial dysfunction and a novel mechanism of action for Ropinirole in this context.

4. Key Results

A. Pathological Phenotypes of TDP-43 Mutant iMGLs

• TDP-43 Mislocalization: Mutant iMGLs exhibited cytoplasmic accumulation of TDP-43 and an increased nucleocytoplasmic ratio.
• Hyper-reactive Phagocytosis: Contrary to some reports of impaired phagocytosis, mutant iMGLs showed enhanced phagocytic activity, suggesting a hyper-reactive, primed state.
• Oxidative Stress & Apoptosis: Mutant cells displayed significantly elevated Reactive Oxygen Species (ROS) levels and increased Caspase-3/7 activity under steady-state conditions.
• Autophagy/Mitophagy Deficits: There was impaired autophagic flux (reduced LC3B accumulation upon bafilomycin treatment) and reduced mitophagy (decreased TOM20-LC3B colocalization).
• Inflammatory Dysregulation: Upon LPS stimulation, mutant iMGLs secreted higher levels of pro-inflammatory cytokines (IL-8, TNF-α) and lower levels of anti-inflammatory cytokines (IL-6, IL-10).
• Iron Homeostasis: Mutant cells showed reduced L-Ferritin protein levels, indicating disrupted iron storage.

B. Effects of Ropinirole (ROPI) Treatment

• Oxidative Stress Reduction: ROPI treatment significantly reduced ROS levels and Caspase-3/7 activity in mutant iMGLs.
• Cytokine Modulation: ROPI partially restored cytokine homeostasis, reducing the pro-inflammatory shift.
• Transcriptomic Rescue: RNA-seq revealed that ROPI treatment shifted the transcriptional profile of mutant iMGLs closer to the wild-type control.
  • Restored Pathways: Normalized expression of genes related to oxidative stress response, protein folding, and extracellular matrix (ECM) organization.
  • Splicing: ROPI influenced RNA splicing-related genes; specifically, it modulated STMN2 transcripts (reduced cryptic exon expression), a hallmark of TDP-43 loss of function.
• Limitations of ROPI: ROPI did not restore the enhanced phagocytic activity, nor did it normalize the impaired autophagy/mitophagy flux or L-Ferritin protein levels. However, it did restore FTH1 (Ferritin Heavy Chain) transcript levels.

C. Mechanistic Discovery: PI3K-mTOR Pathway

• CMap Analysis: Computational analysis identified PI3K-Akt-mTOR inhibitors as top candidates capable of reversing the TDP-43 mutant signature.
• ROPI and mTOR: Further analysis revealed that ROPI itself modulates the mTOR signaling pathway. Heatmaps showed that key mTOR-related transcripts were upregulated in mutant iMGLs and partially normalized by ROPI.
• Conclusion on Mechanism: ROPI likely exerts its neuroprotective and anti-inflammatory effects in microglia, at least in part, by modulating the PI3K-Akt-mTOR axis, independent of direct autophagy induction.

5. Significance

• Broadening ALS Therapy: This study shifts the therapeutic paradigm from a neuron-centric view to a dual-target approach, validating that targeting microglial dysfunction is crucial for ALS treatment.
• Drug Repurposing: It provides strong preclinical evidence for repurposing Ropinirole (currently used for Parkinson's) for ALS, specifically for its ability to mitigate neuroinflammation and oxidative stress in non-neuronal cells.
• Pathway Identification: The identification of the PI3K-mTOR pathway as a central node in TDP-43 microglial pathology offers a new therapeutic axis. It suggests that while direct autophagy inducers might be needed for clearance, modulating mTOR signaling can restore homeostasis and reduce inflammation.
• Model Utility: The isogenic iMGL platform serves as a robust tool for future drug screening and for understanding the early, cell-autonomous mechanisms of neuroinflammation in ALS before neuronal death occurs.

In summary, the paper demonstrates that TDP-43 mutations cause intrinsic microglial dysfunction characterized by oxidative stress and inflammation, and that Ropinirole can mitigate these effects via the PI3K-mTOR pathway, offering a promising integrated treatment strategy for ALS.